Seung Taek Lim

6PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2022
Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer.

Jean Schneider, Ye Won Jeon, Young Jin Suh

|Oct 15, 2021
Neutrophil to Lymphocyte Ratio after Treatment Completion as a Potential Predictor of Survival in Patients with Triple-Negative Breast Cancer.

Kwang-Min Kim, Hyang Suk Choi, Hany Noh

|Feb 15, 2021
Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy.

Ye Won Jeon, Seung Taek Lim, Hongki Gwak

|Nov 06, 2020
Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy.

Ye Won Jeon, Seung Taek Lim, HongKi Gwak

|Nov 06, 2020
Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer.

Seung Taek Lim, Ye Won Jeon, Hongki Gwak

|Jun 30, 2020
Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients.

Jean Schneider, Hyouk Jin Lee, Seok Jin Nam

Pageof 1

Frequent Collaborators

4 joint publications

Hongki Gwak

3 joint publications

Ye Won Jeon

2 joint publications

Young Jin Suh

2 joint publications

Seon Young Park